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ABSTRACT 
Oligodendrocytes, the myelinating cells of the CNS, are derived postnatally from 
oligodendrocyte precursors (OPs) of the subventricular zone (SVZ). However, the 
mechanisms that regulate their generation from SVZ neural stem cells (NSC) are 
poorly understood. Here, we have examined the role of glycogen synthase kinase 3β 
(GSK3β), an effector of multiple converging signalling pathways in postnatal mice. 
The expression of GSK3β by rt-qPCR was most prominent in the SVZ and in the 
developing white matter, around the first 1-2 weeks of postnatal life, coinciding with 
the peak periods of OP differentiation. Intraventricular infusion of the GSK3β inhibitor 
ARA-014418 in mice aged postnatal day (P) 8-11 significantly increased generation 
of OPs in the dorsal microdomain of the SVZ, as shown by expression of cell specific 
markers using rt-qPCR and immunolabelling. Analysis of stage specific markers 
revealed that the augmentation of OPs occurred via increased specification from 
earlier SVZ cell types. These effects of GSK3β inhibition on the dorsal SVZ were 
largely attributable to stimulation of the canonical Wnt/β-catenin signalling pathway 
over other pathways. The results indicate GSK3β is a key endogenous factor for 
specifically regulating oligodendrogenesis from the dorsal SVZ microdomain under 
the control of Wnt-signalling. 
Page 2 of 35
John Wiley & Sons, Inc.
GLIA
  
3 
 
INTRODUCTION 
Oligodendrocytes (OLs) are the myelinating cells of the CNS and are essential for 
normal salutatory conduction. OLs in the postnatal forebrain are derived from 
oligodendrocyte precursors (OPs) that originate from neural stem cells (NSCs) within 
the subventricular zone (SVZ) of the lateral ventricle (LV). NSCs first give rise to 
cycling neural progenitors (NPs) (also known as Type-C cells), identified by their 
expression of the transcription factor (TF) Mash1 and S-phase markers, which then 
differentiate into OPs or olfactory neurons (Kessaris et al. 2006; Marshall et al. 2005; 
Menn et al. 2006; Nakatani et al. 2013; Richardson et al. 2006). The mechanisms 
regulating SVZ-derived OP specification from Type-C cells are unresolved, but are 
believed to involve specific environmental and transcriptional and cascades (He and 
Lu 2013). Postnatally, there is evidence that OPs are derived primarily from the 
dorsal SVZ (dSVZ), whereas the lateral SVZ (lSVZ) has the greatest neurogenic 
potential for olfactory neurons (Brill et al. 2009; Kessaris et al. 2006; Marshall et al. 
2005; Menn et al. 2006; Young et al. 2007). Recent studies shed new light on the 
instructive basis of NSC identities in dSVZ and lSVZ microdomains. For example, 
FGF2 increases OP proliferation in the dSVZ and ectopically in the lSVZ 
microdomains during development and into adulthood (Azim et al. 2012b). These 
findings complement our recent study showing an early postnatal role for Wnt-β-
catenin signaling in regulating NSC specification and oligodenrogenesis in the dorsal 
SVZ (Azim et al., 2014), whereas in the adult SVZ Wnt3a strongly increases OL 
proliferation in the dSVZ without affecting lineage choice or proliferation within 
neurogenic clones (Ortega et al. 2013). 
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Glycogen synthase kinase 3β (GSK3β) is a potent negative regulator of multiple 
signalling pathways in neuronal development, most notably Wnt/β-catenin, as well as 
Shh and Notch1 (Grimes and Jope 2001; Kim et al. 2011). In unstimulated cells, 
GSK3β primes β-catenin for destruction and in the presence of canonical Wnt 
ligands, β-catenin translocates to the nucleus to target specific sets of genes 
associated with Wnt-signalling (Doble and Woodgett 2003). Since canonical Wnt/β-
catenin signalling appears to regulate OL and NP generation in the early postnatal 
SVZ (Azim et al., 2014), but only OLs in the adult SVZ (Ortega et al., 2013), we 
wished to determine the mechanisms of GSK3β and Wnt/β-catenin on OPs and NPs 
during the peak of oligodendrogenesis from the postnatal SVZ in the second week 
postnatal. The results show that at P8-11, the major period of OL generation in 
subcortical white matter (Azim et al., 2011), GSK3β/Wnt/β-catenin is a major 
determinant of OL generation specifically in the dorsal microdomain of the SVZ. 
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MATERIALS AND METHODS 
Animals 
Mice aged postnatal day (P)8-11 were used throughout. All animal procedures were 
performed in accordance with the UK Home Office Animals Scientific Procedures Act 
(1984). Wild-type mice (C57/BL6) were used and transgenic mice of C57/BL6 
background in which fluorescent reporters were driven by Sox10–EGFP mice to 
identify OPs and OLs as previously characterised (Azim et al. 2012b). 
 
In vivo injections 
Pups of similar size litters were used throughout. Intraventricular injections of the 
GSK3β inhibitor ARA-014418 (Bhat et al. 2003) were performed daily for 3 days 
commencing at P8 and brains examined at P11, as previously described (Azim and 
Butt 2011). In brief, mice were deeply anaesthetised under isofluorane and ARA-
014418 (Sigma-Aldrich) was delivered into the cerebrospinal fluid of the LV using a 
Hamilton syringe, at a point 2 mm from the midline along the Bregma, and to a depth 
of 2 mm. ARA-014418 was stored in DMSO, and diluted in sterile saline vehicle and 
delivered in a volume of 2 µl; sterile saline/DMSO vehicle was used as controls and 
referred to as controls only throughout. The growth factors PDGF-AA, IGF1 and 
FGF2 were used at 5 µg/ml in volumes of 2 µl, as in our previous studies (Azim et al. 
2012b; Butt et al. 1997; Goddard et al. 1999). The growth factors Wnt3a, EGF and 
BMP4 were used at 2.5 µg/ml in volumes of 2 µl, in accordance with their effective in 
vitro concentrations in NSC cultures (Lie et al. 2005), and accounting for the dilution 
effects of injected agents (Azim and Butt 2011). Shh was injected at 100 µg/ml in a 
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volume of 2 µls, as previously reported (Jiao and Chen 2008). Wnt3a, BMP4, IGF1, 
PDGF-AA and EGF were obtained from R&D Systems, Shh was obtained from 
eBiosciences and FGF2 obtained from Peprotech, USA. 
 
Immunohistochemistry 
Published protocols were followed for immunolabelling (Azim and Butt 2011; Azim et 
al. 2012b). In brief, brains were immersion fixed in 4% paraformaldehyde and 
coronal vibratome sections of 20 µm to 100 µm thickness were cut through the 
periventricular forebrain. Primary antibodies used were: rabbit anti-PDGFαR (1:400, 
gift from Prof Stallcup; or 1:100, Abcam); goat anti-PDGFRα(1:200, R&D Systems); 
rat anti-MBP (1:300, Millipore); mouse anti-Nestin (1:300, BD Biosciences); rabbit 
anti-Nestin (1:300, R&D Systems); rabbit anti-GFAP (1:300, DAKO); mouse anti-
nuclear pβ-Catenin (1:300, Abcam); goat anti-Tyr216-pGSK3β (1:100, Santa Cruz); 
goat anti-Ser9-pGSK3β (1:100, Santa Cruz); mouse anti-PCNA (1:400, Sigma-
Aldrich); mouse anti-Mash1 (1:200, BD Biosciences). Appropriate species-matched 
secondary antibodies conjugated with Alexafluor 488, 568 or 405 (1:500, Molecular 
Probes) were used. Primary antibodies of different origin were diluted together in 
blocking buffer and co-dilutions of the appropriate secondary antibodies were used. 
Control experiments were performed using appropriate blocking peptides where 
available or otherwise by omission of the primary antibody. For PCNA or Mash1 
labelling, antigen retrieval was performed, whereby free-floating sections were pre-
treated with PBST and NP-40 1% for 20 mins to permeate the sections, and 
following washes in PBS, sections were immersed in pre-boiled citric acid and 
heated in a commercial microwave pressure cooker at full power for 30 sec for 2 
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cycles. For nuclear β-catenin, Ser9-pGSK3β, and Tyr216-pGSK3β, treated brains 
were fixed for 3 hrs in Histochoice Fixative (Sigma-Aldrich). PBS was replaced by 
TBS (0.5M Tris Base, 9% NaCl, pH 8.4) throughout, to reduce non-specific labeling 
of anti-phospho antibodies. For pGSK3β detection, sections were incubated in 
Proteinase K (20 µg/ml in TBS, Invitrogen) for 20 mins at 37ºC followed by 
incubation in 1% SDS for 1 hr at RT and several washing steps. After final washes in 
PBS, tissues were mounted on poly-lysine coated glass slides with Vectashield 
mounting media (Vector Laboratories) and sealed with coverslips. Images were 
acquired using an LSM 5 Pascal Axioskop2 or LSM 510 meta confocal microscope 
(Zeiss). Fluorescence was visualized at 488nm (green), 568nm (red) and 405nm 
(blue) using argon, HeNe1 and diode lasers respectively, using a x40 oil immersion 
lens with high numerical aperture (1.3nm). 
 
Cell counts 
Rostral periventricular coronal sections containing the LV were analysed (>3 
sections per brain, n>4 animals per group) at rostro-caudal axis 0.6 – 0.9 relative to 
the Bregma; counts of OL and OP cell numbers confirmed that there were no 
significant differences between sections in untreated controls (Azim and Butt 2011; 
Azim et al. 2012b). Images were processed with Zeiss LSM Image Examiner (V. 
5.2.0.121), maintaining the acquisition parameters constant to allow comparison 
between samples. Coronal sections were used throughout and cell counts performed 
in the dSVZ, lSVZ andcorpus callosum/periventricular white matter  on flattened 
confocal z-stacks, of 230 µm2 x 230 µm2 in the x-y-plane, and 30 µm in the z-plane. 
Extracellular markers were quantified via a nuclear counterstain (propidium iodide 
(Sigma-Aldrich) or DAPI (Molecular Probes/Invitrogen)). Counts are expressed as 
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mean (SEM, n≥4) cells per field of view volume (FOV) of 1.6 x106 µm3, where the ‘n’ 
value represents the number of mice and the standard error of the mean (SEM).Cell 
counts were tested for significance using GraphPad Prism v302, for unpaired t-test 
(referred to as t-test) or ANOVA followed by Bonferroni’s posthoc test as appropriate. 
 
SVZ microdissection and gene expression profiling  
Published protocols were followed for microdissection of the SVZ microdomains and 
subsequent RNA procedures (Azim et al. 2012b). ARA-014418 or saline/DMSO was 
injected into the LV as above at P8 and at P9 animals were sacrificed ~2.5 hrs after 
last treatment by cervical dislocation. A litter of pups were pooled to yield 1 ‘n’ value. 
Primers used were: GAPDH, forward CAGCAATGCATCCTGCACC reverse 
TGGACTGTGGTCATGAGCCC; Mash1 forward, GACTTTGGAAGCAGGATGG, 
reverse GCTGTCTGGTTTGTTTGTTTC; Axin2: forward 
GGGGGAAAACACAGCTTACA, reverse ACTGGGTCGCTTCTCTTGAA; Fzdl1: 
forward CAAGGTTTACGGGCTCATGT, reverse GTAACAGCCGGACAGGAAAA; 
GSK3β: forward GTGGTTACCTTGCTGCCATC, reverse 
GACCGAGAACCACCTCCTTT; ABCG2 forward, 
CTCAACCTGCCCATTTCAAATGCT, Reverse GTTGGA 
AGTCGAAGAGCTGCTGAGA; Nestin 
ForwardTACAGGACTCTGCTGGAGGCTGAGA, Reverse 
CTGGTATCCCAAGGAAATGCAGCTT; Cyclin D1 Forward 
CTGGATGCTGGAGGTCTGTGAGG, Reverse CTGCAGGCGGCTCTTCTTCAAG; 
Lef1 Forward, CGTCACACATCCCGTCAGATGTC, Reverse 
TGGGTGGGGTGATCTGTCCAACG; Axin2 Forward 
GGGGGAAAACACAGCTTACA, Reverse ACTGGGTCGCTTCTCTTGAA; Olig2 
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Forward GACGATGGGCGACTAGACA, Reverse CAGCGAGCACCTCAAATCTA; 
PDGFRα Forward AGAAAATCCGATACCCGGAG, Reverse 
AGAGGAGGAGCTTGAGGGAG; Sox4 Forward GAACGGAATCTTGTCGCTGT 
; Reverse GAACGCCTTTATGGTGTGGT. ID2 Forward 
CTCCTGGTGAAATGGCTGAT, Reverse GCTTATGTCGAATGATAGCAAAG, 
STAT1 Forward TCTGAATATTTCCCTCCTGGG, Reverse 
CGGAAAAGCAAGCGTAATCT; Hes5 Forward TAGTCCTGGTGCAGGCTCTT 
, Reverse GCTGCTGGAGCAGGAGTTC; Hes3 Forward 
CGCTGGGATGCTGAATTAGT, Reverse GCTGTCTCTCCTTACCGCTG; Hes1 
Forward GGTATTTCCCCAACACGCT, Reverse GAAAGATAGCTCCCGGCATT.  
 
Canonical Wnt-target genes were selected from the following 
resource:http://www.stanford.edu/group/nusselab/cgi-bin/wnt/target_genes. Those of 
TGFβ/BMP resulting in downstream SMAD signalling activation were selected based 
on previous studies (Fei et al. 2010; Ota et al. 2002). Primers for Notch1-target gene 
expression (Hes1, Hes3 and Hes5) were selected based on previous studies in OP 
cultures (Wu et al. 2012; Zhou and Armstrong 2007). Primer Express 1.5 software 
was used to design primers and synthesized by Finnzymes. Gene expression data 
are presented as mean and the SEM, and samples were compared for significance 
using t-test as above. 
 
SVZ microdissection and western blot 
Animals were sacrificed 45 min after the final injection of ARA-014418or vehicle and 
SVZ microdomains were rapidly microdissected, snap frozen, centrifuged briefly at 
4000 x g to obtain tissue pellets for protein extraction in ice cold lysis buffer 
containing protease inhibitors, as previously described (Azim and Butt 2011). Lysed 
tissue supernatant was transferred to Ultrafree MC centrifugal spin columns 
(Millipore) for separation and concentration of protein extracts above 15KDa. 
Purification of cytoplasmic and nuclear extracts were obtained using the “NE-PER 
Nuclear and Cytoplasmic Extraction” kit (Thermo Fisher Scientific, Illinois, US) and 
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protein concentration determined by Bradford protein assay. Subsequent standard 
procedures were followed for western blot. Primary antibodies used were: mouse 
anti-total GSK3β (1:2000, BD Biosciences); mouse anti-nuclear pβ-Catenin (1:1000, 
Abcam); mouse anti-β-Catenin (1:2000, Abcam); mouse anti-β-actin (1:10000, 
Sigma-Aldrich); goat anti-Tyr216-pGSK3β (1:500, Santa Cruz); goat anti-Ser9-
pGSK3β (1:500, Santa Cruz); mouse anti-Notch1 intracellular cleaved component 
(NICD) (1:1000, Millipore); rabbit Anti-phospo-SMAD1/5/8 (1:1000, Cell Signaling); 
Anti-Gli1 (1:1000, Cell Signaling); rabbit Anti-Histone H3 (1:4000; Millipore); rabbit 
anti-Phospo-Erk1/2 (1:1000, Cell Signaling); mouse anti-total Erk1/2 (1:2000, Cell 
Signaling). Proteins were visualized by enhanced chemilluminescent detection 
(Amersham Biosciences), and signal intensities measured via ImageJ software (NIH) 
and normalised to β-actin or H3 internal controls as appropriate. Experiments were 
repeated independently at least 3 times and band densitometry values tested for 
significance using unpaired t-test or ANOVA followed by Bonferroni’s posthoc test.  
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RESULTS 
Regional expression and activity of GSK3β in SVZ microdomains 
We have shown that GSK3β is implicated in OL differentiation in the developing 
white matter (Azim and Butt 2011), but it is not clear whether GSK3β regulates the 
generation of OPs in the postnatal SVZ. To examine this, we determined 
spatiotemporal differences in GSK3β expression by qPCR of microdissected dSVZ 
and lSVZ compared to corpus callosum (CC) at differing postnatal ages and in the 
adult. Transcript levels were normalised against GAPDH housekeeping gene by the 
comparative ∆∆-CT method (Azim et al. 2012b) and expression values compared for 
statistical significance by ANOVA followed by Bonferroni’s test (Fig. 1A,B). Overall, 
spatial expression was greatest in the dSVZ at P4 (Fig. 1A; p<0.05), and in the 
corpus callosum at P8-P11 (Fig. 1A; p<0.05). Levels in the corpus callosum fell 
markedly in the adult (Fig. 1B, p<0.01), whereas overall levels were significantly 
greatest at P8 in both microdomains of the SVZ (Fig. 1B; p<0.01), although they 
remained fairly constant at all ages. The results are consistent with GSK3β being 
most active during the peak period of OL generation in the postnatal forebrain. We 
tested this directly by measuring GSK3β activity in the SVZ following infusion of the 
GSK3β inhibitor ARA-014418, as detailed previously (Azim and Butt, 2011; Azim et 
al., 2014). GSK3β activity was determined by immunostaining for Ser9-pGSK3β as a 
marker for the inactive form of GSK3β and Tyr216-GSK3β as a marker for the active 
form (Cohen and Goedert 2004). Immunostaining demonstrates GSK3β activity in 
both dSVZ and lSVZ (Fig. 1C-F) in dSVZ OPs (Fig.1G-J), and western blot shows 
inhibition was significantly greater in the dSVZ microdomain (Fig. 1K, L p<0.05, 
ANOVA followed by Bonferroni’s post-hoc test). Two-thirds of OPs in the corpus 
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callosum, which at this age are derived from the dSVZ (Kessaris et al. 
2006),expressed ‘active’ Tyr216-pGSK3β in controls, and this was significantly 
decreased following treatment with ARA-014418 (from 64% ± 8% of PDGFRα cells 
(n=4) to 33.8% ± 6.5% of PDGFRα cells (n=5); p<0.01, t-test), with a concomitant 
increase in the ‘inactive’ form Ser9-pGSK3β (from 27.5% ± 3.3% of PDGFRα+ cells 
in controls (n=4) to 72.3% ± 7.6% of PDGFRα+ cells in ARA-014418 (n=5); p<0.01, 
t-test). These data show that GSK3β is effectively inhibited by LV infusion of ARA-
014418 and demonstrate prominent endogenous GSK3β activity in the SVZ, with 
greatest activity at P8-11 in the dSVZ microdomain, the time and site of greatest OP 
generation postnatally. ARA-014418 is not known to have off-target effects on other 
kinases (Bhat et al. 2003) as described previously (Azim and Butt, 2011; Azim et al., 
2014). 
 
GSK3β regulates generation of OPs predominantly from the dSVZ 
microdomain 
The data presented above indicates that GSK3β activity is greatest postnatally in the 
dSVZ microdomain, which a number of studies indicate is the primary source of OPs 
that migrate to populate the forebrain during this period (Kessaris et al. 2006). We 
therefore examined whether GSK3β specifically regulates the generation of OPs in 
the dSVZ, using transgenic mice in which the lineage-specific transcription factor 
Sox10 drives the expression of EGFP (Fig. 2). Inhibition of GSK3β with ARA-014418 
markedly increased the density of Sox10-EGFP+ cells in the SVZ and surrounding 
periventricular white matter (PVWM), compared to controls (Fig. 2A, B). Detailed 
examination of the dSVZ and lSVZ microdomains showed that by far the 
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predominant effect of GSK3β is on the dSVZ, where Sox10-EGFP+ cells were 
significantly increased 3-fold (Fig. 2 C, D ,G; p<0.01,  t-test), and in the adjacent 
PVWM (Fig. 2I), compared to a small although statistically significant effect on the 
lSVZ (Fig. 2 E, F, H). These findings are consistent with GSK3β activity being 
greatest in the dSVZ microdomain and having a primary role in regulating the 
generation of OPs from this micodomain, resulting in an increase in the number of 
OLs in the overlying PVWM. 
 
GSK3β negatively regulates the generation of OPs and neural progenitors 
(NPs) within specific SVZ microdomains 
The results presented above indicate GSK3β activity in the lSVZ, but that its 
inhibition did not markedly alter OP numbers in this microdomain, suggesting 
GSK3β mainly regulates OP generation from the dSVZ. Therefore, we next 
examined the effects of GSK3β inhibition on NSCs and their progeny by qPCR of 
microdissected microdomains (Fig. 3A-C) and immunostaining (Fig. 4A-D). As 
described previously (Azim et al. 2012a; Azim et al. 2012b) the SVZ is delineated up 
to 70 µm from the ependymal wall, based on labelling and aided by nuclear markers. 
Transcripts enriched in early SVZ cells, ABCG2 and Nestin, were significantly 
increased by ARA-014418 in both SVZ microdomains, indicative of an increase in 
NSCs (Fig. 3A; p<0.05, t-test), whereas the NP marker Mash1, and the OP markers 
Olig2 and PDGFRα were differently altered in the two microdomains (Fig. 3B, C). 
Transcripts for Mash1, which is expressed by NPs that generate both neurons and 
OLs, were significantly increased in both microdomains, but the effect was greatest 
in the dSVZ, where it was barely detectable in controls and reached expression 
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levels similar to the control lSVZ following GSK3β inhibition (Fig. 3B). In contrast, 
GSK3β inhibition markedly increased the OL lineage or OP transcripts Olig2 and 
PDGFRα respectively, by over 3-fold in the dSVZ (Fig. 3C; p<0.01, t-test), with levels 
in the lSVZ being very low and in the case of PDGFRα not statistically affected by 
GSK3β inhibition. Immunohistochemical examination of the potential origins of OPs 
from the dSVZ indicates GFAP+ NSCs and Sox10-EGFP+ cells were segregated 
populations (Fig.4A,B). In contrast, GSK3β inhibition resulted in striking increases in 
the dSVZ of Sox10-EGFP co-expression with the NSC/NP marker Nestin (Doetsch 
et al. 1997) (Fig.4C-E) and the NP marker Mash1 (Fig. 4F-H), consistent with 
previous reports of early or new OPs expressing Mash1 (Nakatani et al. 2013). 
Notably, GSK3β inhibition induced a massive expansion in Mash1+ cells dSVZ, and 
a significant (p<0.001; t-test) three-fold increase in the proportion of Mash1+/Sox10- 
cells (arrows; Fig. 4G,H). Mash1 expression in OPs is confined to the earliest stage 
of their differentiation and is transient, hence the large increase in Mash1+/Sox10- 
cells is consistent with these cells generating the increase in Sox10+/Mash1- OPs 
(Ortega et al. 2013; Nakatani et al. 2013). The remaining proportion of Mash1+ cells 
that do not express Sox10-EGFP are Type-C cells and a small fraction of Mash1 
expressing neuroblasts (Azim et al. 2012a; Parras et al. 2004; Smith and Luskin 
1998)(Azim et al. 2012a; Parras et al. 2004; Smith and Luskin 1998). Double 
immunolabelling for PDGFRα with PCNA (proliferating cellular nuclear antigen) 
demonstrated a doubling in PDGFRα+ OP and PDGFRα- cells within the dSVZ 
following GSK3β inhibition, the latter indicative of potential and likely NSC 
proliferation (Fig.4 I-K; p<0.001, t-test). These findings indicate that GSK3β regulates 
the generation of NP in both the dSVZ and lSVZ, while regulating the generation of 
OP in a region-specific manner. Cell death was examined using propidium iodide 
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labelling, but in all cases was low in controls and following treatment, in line with our 
previous study (Azim and Butt et al 2011).  
 
GSK3β differentially regulates multiple targets in SVZ microdomains 
GSK3β is known to modulate several signalling pathways in neural development, 
most notably Wnt and notch1 pathways (reviewed in (Grimes and Jope 2001; Kim 
and Snider 2011), which we previously showed were mechanisms by which GSK3β 
regulates OL differentiation in the optic nerve (Azim and Butt 2011). We therefore 
examined this in the SVZ microdomains using western blot and qPCR (Fig. 5). In the 
P9 SVZ, cytosolic bound β-catenin was increased in both dSVZ and lSVZ 
microdomains following ARA-014418 (Fig. 5A, B), whereas nuclear levels of β-
catenin were increased to a significantly greater extent in the dSVZ (Fig. 5C, D; 
p<0.01, t-test). Moreover, within cytoplasmic extracts, the levels of Erk1/2 were not 
affected by ARA-014418, indicating it did not have off target effects on other growth 
factor-related signalling pathways (Fig. 5A). In addition, we measured nuclear 
accumulation of the transcription form of Notch1 (NICD), together with BMP 
signalling via pSMAD1/5/8 and Gli1 for Shh-signalling (Fig. 5C-E). Nuclear levels of 
activated cleaved Notch1 (NCID) were reduced similarly in both SVZ microdomains 
(p<0.05; t-test), whereas BMP-signalling was only decreased in the dSVZ (p<0.05; t-
test), and Gli1 was marginally, but significantly, increased in the lSVZ, consistent 
with greater Shh expression in this microdomain (p<0.05, t-test) (Azim et al. 2012b; 
Palma et al. 2005). These effects were further validated by qPCR of microdissected 
dSVZ assayed ~2.5 h following ARA-014418infusion (Fig. 5F). Transcripts for β-
catenin target genes cyclin D1, Axin2 and Lef1 were all significantly increased by 
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almost 3-fold in the dSVZ following GSK3β inhibition (Fig. 5F; p<0.01, t-test). By 
comparison, the Notch1 target Hes3 and Hes5 genes were marginally but 
statistically significantly downregulated, whereas Hes1 was not statistically altered 
(p<0.05; t-test), as was the case for BMP signalling - Sox4, ID2, Stat1 (Fig. 5F). 
These findings suggest that the predominant effect of inhibiting GSK3β in the dSVZ 
microdomain is largely attributed to the Wnt pathway, with little effect on other 
pathways that may regulate oligodendrogenesis in the postnatal SVZ. 
 
FGF2 and Wnt3a act by inhibiting GSK3β 
The effects of ARA-014418 demonstrate that endogenous GSK3β regulates the 
generation of OPs in the postnatal SVZ. Several trophic factors are known to 
regulate NSC fate and OP differentiation, including FGF2 and Wnt (Azim and Butt, 
2011; Azim et al., 2012; Azim et al., 2014), and so we examined whether these may 
act to inhibit GSK3β in a manner similar to ARA-014418 (Fig. 6A, C). Growth factors 
were infused into the LV of P9 pups and animals sacrificed 45 min later and 
microdissected dSVZ analysed by western blot of cytosolic extracts for Ser9 
pGSK3β. Compared to controls, we found that only FGF2 and Wnt3a inhibited 
pGSK3β (Fig. 6A, C; p<0.01, test), and we confirmed that Wnt3a and ARA-014418 
acted to increase nuclear β-catenin translocation (Fig. 6B, D; p<0.01, t-test), as did 
FGF2, but to a lesser extent (p<0.05; t-test). In addition, EGF appeared to reduce 
Ser9 pGSK3β via unknown mechanisms, but this was not examined further. 
Intriguingly, BMP4 and EGF reduced nuclear β-catenin (p<0.01, t-test) (Fig. 6C, D), 
whereas other growth factors (IGF1, PDGF-AA and Shh) did not affect pGSK3β or 
nuclear β-catenin. Hence, inhibition of GSK3β with ARA-014418 primarily mimics the 
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effects of endogenous canonical Wnts on the dSVZ and to a lesser extent FGF2, 
consistent with previous findings (Azim et al. 2012b; Azim et al., 2014; Ortega et al. 
2013). 
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DISCUSSION 
Multiple cues control the numbers of OPs, but the factors that regulate their 
generation from germinal SVZ cells is unclear. Here, we show that inhibition of 
GSK3β with ARA-014418 profoundly stimulated the expansion of NPs in the dSVZ 
and their differentiation into OPs derived from this microdomain. The results 
demonstrate that oligodendrogenesis is strongly regulated by GSK3β predominantly 
in the dSVZ microdomain and suggest that it acts mainly via the canonical Wnt/β-
catenin pathway. 
 
The default source of SVZ-derived oligodendrogenesis under specific demyelinating 
or growth factor conditions appears to be dSVZ (Azim et al. 2012b; Azim et al., 2014), 
consistent with this microdomain in generating most of the forebrain derived OL 
lineage cells during postnatal development (Kessaris et al. 2006). Inhibiting GSK3β 
resulted in the preferential genesis of OL lineage cells from the dSVZ, mirroring our 
previous observations on Wnt signalling and FGF2 (Azim et al. 2012b; Azim et al., 
2014). Furthermore, we provide evidence that FGF2 acts in part to inhibit GSK3β, but 
not to the same extent as canonical Wnt-signalling. Targeted genetic ablation of 
GSK3β in NSCs of the developing telencephalon dramatically disrupts neuronal 
maturation whilst NSCs and cycling NPs are massively upregulated (Kim et al. 
2009a). In comparison, targeted β-catenin expression in later OL lineage cells delays 
their differentiation (Fancy et al. 2009; Ye et al. 2009). In addition, inhibitors for 
GSK3β have been used previously in vivo to assess the role of Wnt-signalling in 
determining cell fate in the SVZ and in NSCs (Adachi et al. 2007; Azim et al., 2014; 
Kriks et al. 2011; Maurer et al. 2007). Our findings identify a key role for GSK3β and 
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Wnt/β-catenin in regulating oligodendrogenesis in the forebrain from the proliferating 
(Mash1+) NPs in the dSVZ microdomain. Adachi et al. (2007) have shown that the 
increased proliferation observed in the SVZ results in an increase migration of NPs 
and OPs. Our results suggest that the same might occur in neonates following 
inhibition of GSK3β, since we observed an increase number of NPs and OPs at 
some distance (several hundred micrometers from the SVZ), in particular in the 
dorsolateral corner where many migrating cells converge. Future fate mapping 
studies will be necessary to address the fate of the extra numerous OPs being 
produce after GSK3β inhibition 
 
The SVZ microdomains were assayed by western blot and qPCR for the signalling 
pathways that mediated the increased oligodendrogenesis regulated by GSK3β. 
Inhibition of GSK3β increased nuclear translocation of β-catenin specifically in the 
dSVZ, whereas the activities of Erk1/2, BMP and Shh pathways were not modified, 
indicating a primary effect on the canonical Wnt/β-catenin signalling, and ruling out 
possible cross-talk with other growth factor regulated pathways. Moreover, we 
demonstrated induction of the Wnt target genes Axin2 and Lef1 together with 
increases in OL lineage markers in the dSVZ following GSK3β inhibition, supporting 
recent studies on the importance of Wnt-signalling in OP generation from NSC of the 
doral SVZ microdomain in early postnatal mice (Azim et al., 2014) and adult mice 
(Ortega et al. 2013). With respect to neurogenesis from the dSVZ and lSVZ, the 
effects of GSK3β on Notch1, BMPs and Shh signalling pathways are likely to be 
important (Kim and Snider 2011). The Shh activated transcription factor Gli1 was 
only induced by GSK3β inhibition in the lSVZ, consistent with higher Shh expression 
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in this region at P8 (Azim et al. 2012b; Palma et al. 2005). A mechanism exists for 
GSK3β in negatively regulating downstream Shh signalling (Jia et al. 2002) and has 
been shown in the case of GSK3β ablation in NSCs that promoted Shh signalling at 
least via Gli1 (Kim et al. 2009a). In comparison, Notch1 signalling via NICD nuclear 
activation was reduced dramatically by GSK3β inhibition in the dSVZ compared to 
the lSVZ, implying a greater role for Notch signalling in regulating 
oligodendrogenesis and neurogenesis from the dSVZ microdomain. Earlier studies 
have indicated a direct role for GSK3β in phosphorylating NICD in shortening its half-
life (Foltz et al. 2002), whilst KO of GSK3β in NSCs induces the inverse of promoting 
Notch1 signalling and its target genes in early forebrain development (Kim et al. 
2009a). In addition, Notch1 activity is required to be downregulated for the timely 
differentiation of early OL lineage cells (Wang et al. 1998), which fits with the results 
of our study where GSK3β inhibition promoted OL lineage progression, as observed 
previously in the optic nerve (Azim and Butt 2011). BMPs are strong inhibitors of 
oligodendrogenesis and their downstream TFs work in concert with β-catenin to 
repress maturation in later stage OL lineage cells (Bilican et al. 2008; Weng et al. 
2012). We observed a partial reduction in the downstream BMP pathway factors 
pSMADs1/5/8 in the dSVZ in response to GSK3β inhibition, which has not previously 
been reported in the context of SVZ gliogenesis. However, in cultured dorsal spinal 
cord NPs, FGF2 represses SMADs to induce Olig2 expression (Bilican et al. 2008; 
Weng et al. 2012). The results indicate GSK3b regulates multiple pathways that to a 
certain extent are microdomain specific and may have differential roles in regulating 
oligodendrogenesis and neurogenesis. 
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Extracellular cues that could regulate OP generation via GSK3β and β-catenin were 
examined in the dSVZ. Like ARA-014418, Wnt3a was equally effective in modulating 
GSK3β and β-catenin implicating that GSK3β functions and effects observed are 
equivalent to the canonical Wnt pathway (Azim et al., 2014). Moreover, FGF2 
appears to also regulate GSK3β and β-catenin in the dSVZ, as described in cultured 
NSCs (Israsena et al. 2004). Intriguingly, EGF and BMP4 almost completely 
abolished nuclear β-catenin expression, suggesting they may exert an inhibitory 
effect on endogenous Wnt/β-catenin signalling in the dSVZ. Neurospheres derived 
from the dorsal embryonic forebrain rapidly lose Wnt-signalling in conditions 
containing EGF (Machon et al. 2005), and EGF-signalling could repress β-catenin or 
dorsalising NSC phenotypes.  
 
In summary, these findings are line with our previous study showing GSK3β 
inhibitors increase the number of OLs and promotes myelination in the developing 
corpus callosum and following a chemical demyelinating lesion (Azim and Butt 
2011). Our present study provides further evidence that postnatally the dSVZ is the 
primary source of newly generated OLs in the forebrain, and that their generation 
from NSC/NP is regulated by endogenous GSK3β activity and Wnt signalling in a 
microdomain specific manner (Azim et al., 2014). The failure of remyelination in MS 
is due in part due to upregulation of negative regulatory factors and a loss of positive 
regulatory factors (Franklin and Ffrench-Constant 2008). For example, Notch1 
signalling may be upregulated in multiple sclerosis and delay remyelination by 
inhibiting OPC differentiation (Blanchard et al. 2013; John et al. 2002; Zhang et al. 
2009). Targeting GSK3β through the use of small molecule inhibitors may therefore 
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complement other therapeutic approaches for stimulating OP generation from the 
dSVZ.  
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Figure 1. Functional expression of GSK3β in SVZ microdomains and corpus 
callosum. (A, B) GSK3β expression was measured by qPCR in microdissected 
microdomains of the P8 SVZ (Azim et al. 2012b) and corpus callosum (CC) at 
different ages. GAPDH normalised expression values were compared for statistical 
significance by ANOVA followed by Bonferroni’s test. (C-F) Effects of ARA-014418 
on GSK3β activity were examined by immunostaining for the inactive form Ser9-
pGSK3β in the SVZ microdomains in combination with PI labeling.   (G-J) Expression 
of both Ser9-pGSK3β and the active form Tyr216-pGSK3β in OPs, identified by 
immunostaining for PDGFRα following ARA-014418 treatment. Arrows in C-F show 
examples of pronounced endogenous GSK3β activity in the SVZ before (C, E) and 
after ARA-014418 (D, F).Arrows in G-J indicate increased inactivity in OPs following 
ARA-014418 infusion (G, H) as well as reduction in the active forms of GSK3β 
activities within OPs (I, J). (K, L) Western blot analysis of inactive (ser9) pGSK3β 
and total GSK3β; (L) Data are mean densitometric % changes in values + %SEM 
(error bars) from n>3 replicates (**p<0.01; *p<0.05). Grey bars represent ARA-
014418 and white bars represent controls.  
 
Figure 2. The response of oligodendrocyte lineage cells to ARA-014418 is 
principally in the dSVZ microdomain. (A, B) Overviews show ARA-014418 
induced dramatic increases in the overall density of Sox10+-EGFP+ OL lineage cells 
dorsally (asterisks); double arrows indicate increased OL cells in the lateral wall of 
the SVZ. (C-F) Higher magnification shows a profound effect of ARA-014418 on 
increasing OL lineage cells in the dSVZ microdomain, compared to the lSVZ, where 
OLs were far less numerous (some indicated by double arrows). Scale bar in B = 
100 µm in A, B and scale bar in E = 25 µm in C-F. (G-I) Quantification of Sox10-
EGFP+ cells in the dSVZ (G), lSVZ (H) and PVWM (I); data are mean number of 
cells in a constant volume (FOV), as detailed in methods; error bars represent SEM; 
n>4 animals (*p<0.05;**p<0.01; t-test).Grey bars represent ARA-014418 and white 
bars represent controls. 
 
Figure 3. Inhibition of GSK3β up-regulates markers for NSCs, NPs and OPs 
predominantly in the dSVZ. Real-time qPCR analysis of the dSVZ microdomain 
Page 27 of 35
John Wiley & Sons, Inc.
GLIA
  
28 
 
showing the effects of ARA-014418 on markers for (A) NSCs (ABCG2 and Nestin), 
(B) NPs (Mash1), and (C) OPs (Olig2 and PDGFRα). Expression was normalised to 
the house keeping gene GAPDH. White bars are saline/DMSO treated controls and 
grey bars ARA-014418 treated. Error bars show the SEM (*p<0.05; **p<0.01; t-test). 
 
Figure 4. Inhibition of GSK3β promotes generation of OPs from NSC/NPs of 
the dSVZ. GSK3β inhibition with ARA-014118 resulted in an increase in the dSVZ of 
GFAP+ NSC (A, B), Nestin+ NSC/NPs (C, D), and Mash1+ NPs (F, G), and 
increases the number of Sox10-EGFP+ cells expressing NSC/NP markers (arrows in 
A-G). Quantification of Sox10-EGFP+ cells co-expressing NSC/NP markers are 
given in the histograms. (I-K) There was an increase in proliferating OPs within the 
dSVZ (J, arrows), which was statistically significant (K). Data in E, H, K are mean 
number of cells in a constant FOV (+SEM), n>4 animals per point (**p<0.01, 
***p<0.001, t-test), and white bars represent saline/DMSO-treated controls and grey 
bars ARA-014418 treatment. Scale bar in D = 30 µm in A, B and 20 µm in C, D; 
scale bar in G = 15 µm in F, G (20 µm in insets); scale bar in J = 20 µm I, J. 
 
Figure 5.Inhibition of GSK3β primarily affects the Wnt-β-catenin pathway in the 
dSVZ and lSVZ microdomains. (A, B) Cytosolic extracts were assessed for β-
catenin and pErk, using β-actin and total Erk as loading controls, respectively (A), 
and data plotted as mean (+SEM)changes in % densitometric values (B); n>3 
replicates, **p<0.01, t-test. (C-E) Nuclear extracts were assessed for β-catenin, 
NICD, pSMAD1/5/8 and Gli1, using H3 as loading control (C), and data plotted as 
mean (+SEM) changes in % densitometric values (D, E); n>3 replicates, **p<0.01, 
*p<0.05, t-test or ANOVA followed by Bonferroni’s posthoc test applied as 
appropriate. (F) Transcripts known to be induced via Notch, SMAD (TGFβ/BMP) or 
Wnt-signalling were analysed in the SVZ and data expressed as the mean (+SEM) 
fold-change of relative expression values, normalised to the housekeeping gene 
GAPDH; n>3 replicates, *p<0.05; **p<0.01, t-tests. Grey bars represent ARA-014418 
and white bars represent controls throughout. 
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Figure 6. Growth factor specific regulation of GSK3β and β-catenin in the 
dSVZ. Saline/DMSO, ARA-014418 or a range of growth factors were infused by a 
single intraventricular infusion into the LV of pups and the dSVZ analysed by western 
blot. (A, B) Western blots of cytosolic extracts for pGSK3β (vs. total GSK3β) or for 
nuclear extracts for β-catenin (vs. H3 as internal control). (C, D) Data are expressed 
as mean (+SEM) changes in % densitometric values; n>3 replicates, *p<0.05, 
**p<0.01, ***p<0.001, t-tests vs. control. 
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